SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001214659-24-010989
Filing Date
2024-06-17
Accepted
2024-06-17 06:00:40
Documents
2

Document Format Files

Seq Description Document Type Size
1 d611245424b3.htm 424B3 596909
2 GRAPHIC biodexa_logo.jpg GRAPHIC 13595
  Complete submission text file 0001214659-24-010989.txt   616915
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Filer) CIK: 0001643918 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-279994 | Film No.: 241046848
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)